When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACHV - Achieve completes enrollment in mid-stage study of smoking cessation candidate cytisinicline
Achieve Life Sciences Inc.
Achieve Life Sciences (ACHV-1.5%) has completed the enrollment of 254 subjects in a Phase 2b clinical trial, ORCA-1, evaluating cytisinicline, plus behavioral support, for smoking cessation.
More news on: Achieve Life Sciences, Inc., Healthcare stocks news,